Carol I. Barash, Ph.D.,
Principal

E-Mail: 
 info@gepci.com

Please select a service:

        

    

Innovation Adoption

Research shows that market acceptance of new diagnostics, therapeutics, medical devices, e-health products and services is uncertain even if users’ knowledge, skill and motivational levels are high.  Dr. Barash provides original and effective strategies for reducing the delays to full market acceptance through improved design, revised business plans or marketing strategies, user- friendly demos, white papers, training, and improved communication.

Genetics Education

An innovative leader in Genetics Education, Dr. Barash uses learning theory and customized research on cognitive, attitudinal, normative, environmental and organizational barriers to educate audiences.  A hallmark of her approach is its focus on insuring that trainees know how to use their new knowledge in their daily decision-making and problem solving.  Dr. Barash is an accomplished developer of educational programs (both Web-based and traditional), and an effective lecturer, and writer, to physicians, allied health professionals, the business community, public policy makers, and consumers.

-TOP-

 

Business Strategy

Dr. Barash draws on her broad multidisciplinary network to identify and develop new market niches, broker business to business alliances, and forge public-private partnerships to maximize the actualization of the benefits  genetics can confer.

-TOP-

Ethics

Dr. Barash helps clients to anticipate and meet ethical issues in both research and clinical applications of genetics.  She works closely with industry, legislatures, consumer based groups and health care institutions to evaluate ethical concerns related to DNA collection, data banking, genetic privacy, disclosure of information to third parties and related issues.   Dr. Barash is an expert on genetic discrimination, having directed the first federally funded research study in 1992,and continues to be a leader in this area.

                                                                       -TOP-

Policy Analysis

US and international policy continues to grapple with complex issues arising from new developments in genomics, pharmacogenetics, toxicogenomics, proteomics, diagnomics and evolving related fields.  Dr. Barash works with companies to comment on proposed regulatory changes and to ensure corporate consistency with policy requirements.  Her keen analytic abilities and multidisciplinary approach are strong assets to companies confronting the regulatory and governmental policy challenges of acceptance in markets which can be global, ethnically diverse, and based on distinctly different cultural norms.